Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Dermatologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Melanoma 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Hematologic Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 3trametinib 2pertuzumab 2dabrafenib 2Trastuzumab 2Tacrolimus 2Specimen Handling 2Polymerase Chain Reaction 2Nivolumab 2Biopsy 2ulixertinib 1trastuzumab biosimilar HLX02 1tinostamustine 1temsirolimus 1sonidegib 1selinexor 1sapanisertib 1romidepsin 1relatlimab 1palbociclib 1osimertinib 1omipalisib 1merphos 1larotrectinib 1ipatasertib 1fludarabine phosphate 1erdafitinib 1entrectinib 1defactinib 1copanlisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hematologic Neoplasms × Nurse Clinicians × Dermatologic × Clear all
NCT00179764 2019-08-30

Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC])

Ann & Robert H Lurie Children's Hospital of Chicago

Phase NA Completed
68 enrolled
DermatologicLymphoidMyeloidOther hematologic neoplasm

Melanoma, Neoplasms, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡